Skip to content
OpenCapital
Get started

Allogene Therapeutics ALLO Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.4×+0.1×
Gilead Sciences logo
Gilead SciencesGILD
2×+0.6×
Precigen logo
PrecigenPGEN
4.8×+1.3×
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
18×+2.3×
Sana Biotechnology logo
Sana BiotechnologySANA
1.3×-2.1×
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
10.4×+8.7×

Other financials

Income statement

See full
Revenue-—
Operating income-$46.1M+29.3%
Net income-$42.6M+28.7%
EPS (diluted)-$0.18+35.7%

Balance sheet

See full
Cash & equivalents$40.6M-23.0%
Total debt$81.1M-8.9%
Total equity$278.9M-27.6%
Total assets$396.0M-22.1%

Cash flow

See full
Operating cash flow-$12.9M+75.6%
CapEx$9.0K-90.9%
Free cash flow-$12.9M+75.6%

Valuation

See full
Market cap$711.02M+164%
Enterprise value$751.47M+146%

Profitability

See full
Operating margin-1,241,813.6%-2,018,140pp
Net margin-1,170,863.6%-2,007,890pp
FCF margin-913,609.1%-1,474,890pp

Returns & leverage

See full
Return on equity-52.3%-5.7pp
Debt / equity0.3×+0.1×

Where this comes from

Calculated from Allogene Therapeutics’s reported figures.

total current assets/total current liabilities=9.6×

Based on the most recent quarter.

The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Allogene Therapeutics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Allogene Therapeutics's current ratio?
Allogene Therapeutics (ALLO) reported current ratio of 9.6× in Q1 2026.
How has Allogene Therapeutics's current ratio changed year-over-year?
Allogene Therapeutics's current ratio decreased by 0.7% year-over-year, from 9.7× to 9.6×.
What is the long-term trend for Allogene Therapeutics's current ratio?
Over 5 years (2020 to 2025), Allogene Therapeutics's current ratio has grown at a -2.4% compound annual growth rate (CAGR), from 9× to 7.9×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.